???pagination.result.count???
???pagination.result.page???
1
Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids. , Conti P., J Med Chem. October 6, 2005; 48 (20): 6315-25.
Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket. , Kinarsky L., J Pharmacol Exp Ther. June 1, 2005; 313 (3): 1066-74.
Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. , Morley RM., J Med Chem. April 7, 2005; 48 (7): 2627-37.
The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. , Feng B., Neuropharmacology. March 1, 2005; 48 (3): 354-9.
The micromolar zinc-binding domain on the NMDA receptor subunit NR2B. , Rachline J., J Neurosci. January 12, 2005; 25 (2): 308-17.
Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)- en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride). , Sun L., J Pharmacol Exp Ther. August 1, 2004; 310 (2): 563-70.
Structure-activity analysis of a novel NR2C/ NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. , Feng B., Br J Pharmacol. February 1, 2004; 141 (3): 508-16.
Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner. , Levine JB., Neurosci Lett. August 7, 2003; 346 (3): 125-8.